XML 24 R79.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Sales And Other Financial Information By Business Segment) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Net sales $ 2,215 $ 2,031 $ 2,046 $ 2,015 $ 1,995 $ 1,768 $ 1,758 $ 1,799 $ 8,307 $ 7,320 $ 6,723
Depreciation and amortization                 481 410 385
Income Tax Expense (Benefit)                 341 456 517
Segment net earnings (loss)                 1,686 1,751 1,594
Less acquisition and integration-related charges                 (142)    
Less restructuring charges                 (60)   (49)
Add uncertain income tax position adjustments                 99    
Add gain on sale of property, plant and equipment                   13  
Income (taxes) benefits on repatriation of foreign earnings                   7 (67)
Less impairment of property, plant and equipment         0         (76)  
Less patent litigation gain                     43
Net earnings 401 327 309 308 295 337 319 322 1,345 1,273 1,107
Total assets 12,405       10,895       12,405 10,895 9,071
Capital spending                 225 182 131
Reconstructive [Member]
                     
Net sales                 3,710 3,549 3,384
Depreciation and amortization                 267 250 245
Income Tax Expense (Benefit)                 375 332 276
Segment net earnings (loss)                 926 818 683
Total assets 3,854       3,156       3,854 3,156 3,095
Capital spending                 119 106 71
MedSurg [Member]
                     
Net sales                 3,160 2,803 2,427
Depreciation and amortization                 84 77 66
Income Tax Expense (Benefit)                 165 178 148
Segment net earnings (loss)                 535 481 413
Total assets 2,420       2,333       2,420 2,333 2,011
Capital spending                 56 47 42
Neurotechnology And Spine [Member]
                     
Net sales                 1,437 968 912
Depreciation and amortization                 119 61 52
Income Tax Expense (Benefit)                 63 60 62
Segment net earnings (loss)                 221 188 169
Total assets 2,258       777       2,258 777 563
Capital spending                 27 13 13
Other [Member]
                     
Depreciation and amortization                 11 22 22
Income Tax Expense (Benefit)                 (106) (71) (38)
Segment net earnings (loss)                 (234) (158) (85)
Total assets 3,873       4,629       3,873 4,629 3,402
Capital spending                 23 16 5
Operating Segments [Member]
                     
Income Tax Expense (Benefit)                 497 499 448
Segment net earnings (loss)                 $ 1,448 $ 1,329 $ 1,180